Neurodegenerative disease test kit INNO-BIA

multiparametricfor amyloid betablood

A well standardized multiparameter bead-based immunoassay for the simultaneous quantification of human β-amyloid (Aβ) forms Aβ1-42 and Aβ1-40 in plasma using xMAP® technology.* For simultaneous quantification of different forms of β-amyloid in blood, with check for matrix interference. Standardized quantification of β-amyloid isoforms in blood. * xMAP is a registered trademark of Luminex Corp. For research use only INNO-BIA plasma Aβ forms Product number 81578 2 x 96 Tests Details Features and Benefits User-friendly bead-based immunoassay High performance High analytical assay sensitivity Quantifying Aß1-42 and Aß1-40 in one well, which lowers test variability Low intra- and interassay variability, even at low concentrations High reproducibility Broad dynamic range Ease of use Only one test procedure Six ready-to-use (multiparametric) standards Two run-validation (non-plasma) controls Limited number of handling steps Sample characteristics: EDTA-plasma 1:3 diluted with plasma diluent 25 µL plasma/well Duplicate testing